Form 4: BioRestorative Therapies Director Acquires Stock Options

Patrick F. Williams, a director at BioRestorative Therapies, Inc., acquired stock options for 52,632 shares of common stock on February 14, 2025.

Summary

• Patrick F. Williams, a director of BioRestorative Therapies, Inc., filed a Form 4 on February 18, 2025, reporting a transaction that occurred on February 14, 2025.
• Williams acquired stock options for 52,632 shares of BioRestorative Therapies common stock at an exercise price of $2.46 per share.
• These options vest in twelve nearly equal monthly installments of 4,386 shares, starting March 14, 2025, and continuing monthly until fully vested.
• Following the reported transaction, Williams directly owns options for 10,490 shares (exercise price $5.08, expiration 11/04/2031), 32,028 shares (exercise price $2.91, expiration 02/17/2033), 79,646 shares (exercise price $1.45, expiration 02/13/2034) and 52,632 shares (exercise price $2.46, expiration 02/14/2035).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. While insider buying can be seen as positive, it's not a major event.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the options suggests a long-term commitment from the director.

Industry Context

This filing is a routine disclosure required by the SEC for insider transactions. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates